194 related articles for article (PubMed ID: 9097955)
21. Complementation of null CF mice with a human CFTR YAC transgene.
Manson AL; Trezise AE; MacVinish LJ; Kasschau KD; Birchall N; Episkopou V; Vassaux G; Evans MJ; Colledge WH; Cuthbert AW; Huxley C
EMBO J; 1997 Jul; 16(14):4238-49. PubMed ID: 9250667
[TBL] [Abstract][Full Text] [Related]
22. Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology.
Larbig M; Jansen S; Dorsch M; Bernhard W; Bellmann B; Dorin JR; Porteous DJ; Von Der Hardt H; Steinmetz I; Hedrich HJ; Tuemmler B; Tschernig T
Pathobiology; 2002-2003; 70(2):89-97. PubMed ID: 12476034
[TBL] [Abstract][Full Text] [Related]
23. Tissue-specific in vivo transcription start sites of the human and murine cystic fibrosis genes.
White NL; Higgins CF; Trezise AE
Hum Mol Genet; 1998 Mar; 7(3):363-9. PubMed ID: 9466991
[TBL] [Abstract][Full Text] [Related]
24. Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(delta508) in the lung.
Xu Y; Liu C; Clark JC; Whitsett JA
J Biol Chem; 2006 Apr; 281(16):11279-91. PubMed ID: 16455659
[TBL] [Abstract][Full Text] [Related]
25. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
[TBL] [Abstract][Full Text] [Related]
26. Cystic fibrosis: recent structural insights.
Dorwart M; Thibodeau P; Thomas P
J Cyst Fibros; 2004 Aug; 3 Suppl 2():91-4. PubMed ID: 15463935
[TBL] [Abstract][Full Text] [Related]
27. Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth.
Abraham EH; Vos P; Kahn J; Grubman SA; Jefferson DM; Ding I; Okunieff P
Nat Med; 1996 May; 2(5):593-6. PubMed ID: 8616723
[TBL] [Abstract][Full Text] [Related]
28. Arsenite regulates Cystic Fibrosis Transmembrane Conductance Regulator and P-glycoprotein: evidence of pathway independence.
Maitra R; Hamilton JW
Cell Physiol Biochem; 2005; 16(1-3):109-18. PubMed ID: 16121039
[TBL] [Abstract][Full Text] [Related]
29. HNF1alpha is involved in tissue-specific regulation of CFTR gene expression.
Mouchel N; Henstra SA; McCarthy VA; Williams SH; Phylactides M; Harris A
Biochem J; 2004 Mar; 378(Pt 3):909-18. PubMed ID: 14656222
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
31. Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1.
Conrad S; Viertelhaus A; Orzechowski A; Hoogstraate J; Gjellan K; Schrenk D; Kauffmann HM
Toxicology; 2001 Jan; 156(2-3):81-91. PubMed ID: 11164610
[TBL] [Abstract][Full Text] [Related]
32. Alternative 5' exons of the CFTR gene show developmental regulation.
Mouchel N; Broackes-Carter F; Harris A
Hum Mol Genet; 2003 Apr; 12(7):759-69. PubMed ID: 12651871
[TBL] [Abstract][Full Text] [Related]
33. Expression of the cystic fibrosis gene in human foetal tissues.
Trezise AE; Chambers JA; Wardle CJ; Gould S; Harris A
Hum Mol Genet; 1993 Mar; 2(3):213-8. PubMed ID: 7684639
[TBL] [Abstract][Full Text] [Related]
34. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.
Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM
J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741
[TBL] [Abstract][Full Text] [Related]
35. Expression and regulation of the cystic fibrosis gene during rat liver regeneration.
Tran-Paterson R; Davin D; Krauss RD; Rado TA; Miller DM
Am J Physiol; 1992 Jul; 263(1 Pt 1):C55-60. PubMed ID: 1378998
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model.
Cohen JC; Morrow SL; Cork RJ; Delcarpio JB; Larson JE
Mol Genet Metab; 1998 Jun; 64(2):108-18. PubMed ID: 9705235
[TBL] [Abstract][Full Text] [Related]
37. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
Romey MC
Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
[TBL] [Abstract][Full Text] [Related]
38. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
Pall H; Zaman MM; Andersson C; Freedman SD
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.
Xu Y; Clark JC; Aronow BJ; Dey CR; Liu C; Wooldridge JL; Whitsett JA
J Biol Chem; 2003 Feb; 278(9):7674-82. PubMed ID: 12482874
[TBL] [Abstract][Full Text] [Related]
40. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
